Optimization of Blood Levels of 25(OH)-vitamin D in African Americans
非洲裔美国人血液中 25(OH)-维生素 D 水平的优化
基本信息
- 批准号:10045657
- 负责人:
- 金额:$ 50.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAfrican AmericanAnalysis of VarianceAnimalsAntioxidantsBiologicalBiological AvailabilityBiological MarkersBloodChemistryCholecalciferolClinicalClinical TrialsControlled Clinical TrialsCoupledCysteineDataDevelopmentDiabetes MellitusDiseaseDoseDouble-Blind MethodEnsureFastingFutureGC geneGLUT4 geneGenesGlutathioneGoalsGrantHealthHealth HazardsHumanHydroxylationImpairmentIncidenceInflammationInflammatoryIngestionInsulin ResistanceKidney Function TestsLife StyleLinkLiverMeasurableMediatingMediator of activation proteinMedicalMetabolicMetabolismMixed Function OxygenasesModelingMuscleNatural ProductsNutrientObesityOralOutcomeOxidative StressPainPathway interactionsPhysiologicalPlacebo EffectPlacebosPopulationPrediabetes syndromePregnancy TestsPublic HealthRandomizedRandomized Controlled Clinical TrialsRattusRecommendationRegulationRegulator GenesReportingResearch SubjectsRiskSLC2A1 geneSafetySerumStatistical Data InterpretationSupplementationTNF geneTestingTherapeuticTherapeutic EffectTissuesTranslationsUnited States National Center for Health StatisticsUp-RegulationValidationVisitVitamin AVitamin DVitamin D DeficiencyVitamin D supplementationWhole Bloodcapsulechronic painclinical paincostdelta opioid receptordesigndietary supplementsefficacy clinical trialefficacy trialepidemiology studyexperienceglucose metabolismhealth disparityimprovedliver functionliver metabolismmembermouse modelnovelnovel strategiespreclinical studypreventside effectsuccess
项目摘要
Optimization of 25(OH) vitamin D levels in African Americans
Public Health Issue: Low circulating levels of 25(OH) vitamin D (VD) have been correlated with many
adverse health conditions and health disparities in African Americans (AA). Supraphysiological high-dose VD
supplementation is required to eliminate the differences observed in the levels of circulating 25(OH)VD in AA
and white subjects. However, recent studies have questioned the therapeutic effects of high-dose VD
supplementation.
Rationale: Glutathione (GSH) is a major physiological antioxidant. Recent studies report that low levels of
GSH are linked to 25(OH)VD deficiencies in both animal and human studies. Animal studies using ZDF rats
and a mouse model of 25(OH)VD deficiency have shown that, compared to supplementation with VD-alone,
co-supplementation with VD (cholecalciferol) + L-cysteine (LC, a GSH precursor) led to an improvement in
GSH status that resulted in significant increases in circulating levels of 25(OH)VD and reduced oxidative
stress, TNF-α, and insulin resistance (IR).
Approach: AA have reduced levels of glutathione (GSH), as well as a high incidence of insulin resistance (IR)
and inflammatory disorders. This R33 application presents our design for a randomized, double-blind, placebo-
controlled clinical trial to test the hypothesis that supplementation with VD in combination with L-cysteine (a
GSH precursor) is more successful at optimizing the statuses of 25(OH)VD and GSH [biological signatures]
and simultaneously decreasing TNF-α and IR [functional or clinical outcomes], suggesting a better therapeutic
approach compared with supplementation with VD alone in AA subjects.
Impact on Public Health: The successful completion of this R33 clinical trial will have a significant impact on
the design of future efficacy clinical trials examining co-supplementation using a GSH precursor coupled with
lower VD doses to reduce 25(OH)VD deficiency/inadequacy, inflammation, and IR biomarkers. The
development of a safe, low-cost dietary supplement that can improve 25-hydroxy vitamin D status and reduce
insulin resistance and inflammation would provide significant benefits in the treatment of pre-diabetes and
health disparities, including chronic pain, in the African American population.
This application, which is highly responsive to PAR-18-828, will replicate previous human studies and examine
the outcome of biological signatures by combining the natural product L-cysteine with VD to optimize its
supplementation and efficacy.
非裔美国人25(OH)维生素D水平的优化
公共卫生问题:循环中低水平的25(OH)维生素D(VD)与许多
非洲裔美国人(AA)的不良健康状况和健康差距。超生理学大剂量VD
需要补充以消除在AA中观察到的循环25(OH)VD水平的差异
和白人受试者。然而,最近的研究对大剂量VD的治疗效果提出了质疑
补充。
原理:谷胱甘肽(GSH)是一种主要的生理性抗氧化剂。最近的研究报告说,低水平的
在动物和人类研究中,谷胱甘肽与25(OH)VD缺陷有关。ZDF大鼠的动物实验研究
而25(OH)VD缺乏的小鼠模型表明,与单独补充VD相比,
同时补充VD(胆钙化醇)+L-半胱氨酸(LC,谷胱甘肽前体)可改善
GSH状态导致循环中25(OH)VD水平显著升高,氧化作用降低
应激、肿瘤坏死因子-α和胰岛素抵抗(IR)。
研究方法:再障患者的谷胱甘肽(GSH)水平降低,胰岛素抵抗(IR)的发生率也较高
和炎症性疾病。这个R33应用程序展示了我们设计的随机、双盲、安慰剂-
补充血管性痴呆联合L-半胱氨酸(A)的临床对照试验
GSH前体)更成功地优化了25(OH)VD和GSH[生物标志]的状态
同时降低肿瘤坏死因子-α和IR[功能或临床结果],提示更好的治疗方法
在AA受试者中与单独补充VD的方法进行比较。
对公众健康的影响:这项R33临床试验的成功完成将对
使用GSH前体和辅助剂检查联合补充剂的未来疗效临床试验的设计
较低的VD剂量可减少25(OH)VD缺乏/不充分、炎症和IR生物标志物。这个
开发一种安全、低成本的膳食补充剂,可以改善25-羟基维生素D的状况并减少
胰岛素抵抗和炎症将在治疗糖尿病前期和
非洲裔美国人的健康差距,包括慢性疼痛。
这个应用程序对PAR-18-828高度响应,将复制以前的人类研究并检查
天然产物L-半胱氨酸与VD相结合优化其生物学特征的结果
补充剂和功效。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sushil K Jain其他文献
36 - Manganese Supplementation Lowers Vascular Inflammation by Reducing ROS and Cholesterol Levels Via Downregulation of NOX2 and LDLr in Livers of ZDF Rats
- DOI:
10.1016/j.freeradbiomed.2013.10.450 - 发表时间:
2013-11-01 - 期刊:
- 影响因子:
- 作者:
Elodie Burlet;Sushil K Jain - 通讯作者:
Sushil K Jain
Sushil K Jain的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sushil K Jain', 18)}}的其他基金
Optimization of Blood Levels of 25(OH)-vitamin D in African Americans
非洲裔美国人血液中 25(OH)-维生素 D 水平的优化
- 批准号:
10685725 - 财政年份:2020
- 资助金额:
$ 50.72万 - 项目类别:
Optimization of Glutathione Levels and Alzheimer Disease Risk in African Americans
优化非裔美国人的谷胱甘肽水平和阿尔茨海默病风险
- 批准号:
10475166 - 财政年份:2020
- 资助金额:
$ 50.72万 - 项目类别:
Optimization of Blood Levels of 25(OH)-vitamin D in African Americans
非洲裔美国人血液中 25(OH)-维生素 D 水平的优化
- 批准号:
10248397 - 财政年份:2020
- 资助金额:
$ 50.72万 - 项目类别:
L-cysteine, PIP3 and Insulin Signaling in Diabetes
糖尿病中的 L-半胱氨酸、PIP3 和胰岛素信号传导
- 批准号:
8629232 - 财政年份:2014
- 资助金额:
$ 50.72万 - 项目类别:
Ketosis, Vascular Inflammation and Its Therapy in Type 1 Diabetic Patients
1型糖尿病患者的酮症、血管炎症及其治疗
- 批准号:
8004532 - 财政年份:2009
- 资助金额:
$ 50.72万 - 项目类别:
Ketosis, Vascular Inflammation and Its Therapy in Type 1 Diabetic Patients
1型糖尿病患者的酮症、血管炎症及其治疗
- 批准号:
7266156 - 财政年份:2007
- 资助金额:
$ 50.72万 - 项目类别:
Ketosis, Vascular Inflammation and Its Therapy in Type 1 Diabetic Patients
1型糖尿病患者的酮症、血管炎症及其治疗
- 批准号:
7500667 - 财政年份:2007
- 资助金额:
$ 50.72万 - 项目类别:
Ketosis, Vascular Inflammation and Its Therapy in Type 1 Diabetic Patients
1型糖尿病患者的酮症、血管炎症及其治疗
- 批准号:
7663095 - 财政年份:2007
- 资助金额:
$ 50.72万 - 项目类别:
Adjuvant Therapy for Vascular Inflammation in Diabetes
糖尿病血管炎症的辅助治疗
- 批准号:
7107286 - 财政年份:2004
- 资助金额:
$ 50.72万 - 项目类别:
Adjuvant Therapy for Vascular Inflammation in Diabetes
糖尿病血管炎症的辅助治疗
- 批准号:
6954114 - 财政年份:2004
- 资助金额:
$ 50.72万 - 项目类别:
相似海外基金
Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
- 批准号:
2306671 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
- 批准号:
10714464 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
- 批准号:
10723833 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:
10811498 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
- 批准号:
10593806 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
- 批准号:
2327055 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
- 批准号:
10782674 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
- 批准号:
10738855 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
- 批准号:
23K00376 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neurovascular Control of Renal Blood Flow During Exercise in African American Adults
非裔美国成年人运动期间肾血流的神经血管控制
- 批准号:
10653381 - 财政年份:2023
- 资助金额:
$ 50.72万 - 项目类别:














{{item.name}}会员




